The University of Chicago Medicine has a strong legacy of combining groundbreaking care and agenda-setting research with the goal of improving the lives of all patients with inflammatory bowel disease.
Inflammatory bowel disease is treated from a unified team perspective that includes insights from the nation’s leading gastroenterologists, colon and rectal surgeons, registered dieticians, genetic counselors, advanced practice nurses and more.
Their combined experience means patients are comprehensively treated and managed for their IBD and secondary healthcare needs. While medical management is typically the first line of treatment, surgery may be required in some cases. Our surgeons offer the latest surgical IBD treatment and employ advanced laparoscopic, robotic and minimally invasive approaches, as appropriate, to return patients to their lives as soon as possible.
Following treatment, our team of registered dieticians and ostomy nurses will discuss postoperative lifestyle changes, including possible diet changes as well as ostomy care. Our ultimate goal is to ensure patients are able to stay active and productive long after surgical treatment of IBD.
In addition to our multidisciplinary clinical care program, the University of Chicago Medicine offers unique clinical trials, geared toward investigating possible new therapies for IBD treatment, as well as a monthly support groups for patients and families. The totality of these offerings mean IBD patients are given the support and care they deserve to thrive, from diagnosis through post-operative treatment.